Aaron Wealth Advisors LLC Sells 1,100 Shares of Danaher Co. (NYSE:DHR)

Aaron Wealth Advisors LLC reduced its position in Danaher Co. (NYSE:DHR - Free Report) by 8.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,808 shares of the conglomerate's stock after selling 1,100 shares during the quarter. Aaron Wealth Advisors LLC's holdings in Danaher were worth $2,711,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. FMR LLC boosted its holdings in Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock worth $6,566,116,000 after buying an additional 3,217,631 shares during the period. Massachusetts Financial Services Co. MA grew its position in shares of Danaher by 17.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock worth $996,141,000 after purchasing an additional 535,254 shares in the last quarter. International Assets Investment Management LLC raised its stake in Danaher by 40,196.5% during the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate's stock valued at $119,539,000 after purchasing an additional 428,897 shares during the period. Montrusco Bolton Investments Inc. lifted its holdings in Danaher by 30.4% in the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate's stock worth $465,617,000 after purchasing an additional 397,671 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec boosted its stake in Danaher by 82.4% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 653,375 shares of the conglomerate's stock worth $181,651,000 after purchasing an additional 295,187 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Down 1.4 %

Danaher stock traded down $3.49 during mid-day trading on Friday, hitting $238.41. The company's stock had a trading volume of 3,044,734 shares, compared to its average volume of 2,640,177. Danaher Co. has a one year low of $222.53 and a one year high of $281.70. The stock has a market cap of $172.20 billion, a PE ratio of 45.50, a P/E/G ratio of 4.23 and a beta of 0.83. The company has a 50 day moving average of $234.85 and a 200-day moving average of $253.42. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm's revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the firm posted $2.02 EPS. On average, research analysts anticipate that Danaher Co. will post 7.49 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher's payout ratio is currently 20.61%.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. UBS Group lowered their target price on shares of Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a report on Wednesday, October 23rd. Scotiabank assumed coverage on shares of Danaher in a report on Monday, December 23rd. They set a "sector perform" rating and a $265.00 price objective for the company. Stifel Nicolaus lifted their target price on Danaher from $250.00 to $265.00 and gave the stock a "hold" rating in a report on Wednesday, October 23rd. Bank of America raised Danaher from a "neutral" rating to a "buy" rating and set a $290.00 price target for the company in a research note on Friday, December 13th. Finally, TD Cowen lifted their price objective on Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, Danaher has an average rating of "Moderate Buy" and an average target price of $286.80.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.